Raquel Izumi Selected Research

Raquel Izumi Research Topics

Disease

17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2013
15	Neoplasms (Cancer) 01/2024 - 01/2013
4	Disease Progression 12/2021 - 01/2018
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 01/2018
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 01/2016
3	Diarrhea 01/2021 - 01/2016
2	Lymphoma (Lymphomas) 11/2023 - 01/2016
2	Anemia 01/2022 - 10/2020
2	Neutropenia 01/2022 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2016
2	Infections 11/2021 - 01/2020
2	Headache (Headaches) 01/2021 - 01/2019
2	Cough 01/2021 - 01/2019
2	Lymphocytosis 01/2020 - 02/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016 - 01/2013
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Hyponatremia 01/2022
1	Atrial Fibrillation 11/2021
1	Atrial Flutter (Flutter, Atrial) 11/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Contusions 01/2021
1	Carcinoma (Carcinomatosis) 10/2020
1	Urinary Tract Infections (Urinary Tract Infection) 10/2020
1	Fatigue 10/2020
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2020
1	Inflammation (Inflammations) 01/2020
1	COVID-19 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Anorexia 01/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2016
1	Vomiting 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Lethargy 01/2016
1	Type 2 Diabetes Mellitus (MODY) 12/2007
1	Hepatitis C 05/2004

Drug/Important Bio-Agent (IBA)

21	acalabrutinibIBA 01/2022 - 01/2016
16	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 01/2013
8	ibrutinibIBA 11/2021 - 01/2013
3	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2024 - 01/2022
3	IntegrinsIBA 01/2024 - 01/2022
2	Cyclin-Dependent Kinase 9IBA 11/2023 - 01/2022
2	CamptothecinIBA 09/2023 - 01/2022
2	Positive Transcriptional Elongation Factor BIBA 01/2023 - 12/2021
2	obinutuzumabIBA 01/2020 - 01/2020
1	Serine Proteases (Serine Protease)IBA 01/2024
1	RNA Polymerase II (RNA Polymerase B)IBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	Pancreatic Elastase (Elastase)IBA 09/2023
1	EnzymesIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	vistusertibIBA 11/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2021
1	PlatinumIBA 10/2020
1	pembrolizumabIBA 10/2020
1	Programmed Cell Death 1 ReceptorIBA 10/2020
1	Alanine Transaminase (SGPT)IBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	C-Reactive ProteinIBA 01/2020
1	Chlorambucil (Leukeran)FDA Link 01/2020
1	Immunoglobulin Variable RegionIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Vitamin K FDA Link 01/2020
1	Warfarin (Coumadin)FDA LinkGeneric 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	N- (1- (7- fluoro- 2- (pyridin- 2- yl)quinolin- 3- yl)ethyl)- 9H- purin- 6- amineIBA 10/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2007
1	2,4-thiazolidinedione (thiazolidinedione)IBA 12/2007
1	BiguanidesIBA 12/2007
1	Internal Ribosome Entry SitesIBA 05/2004
1	Viral ProteinsIBA 05/2004
1	RNA (Ribonucleic Acid)IBA 05/2004

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2014
1	Immunotherapy 10/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Aftercare (After-Treatment) 02/2015